Mangalik A - Search Results

1

Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumors.

Movva S, Verschraegen CF, Rabinowitz I, Mangalik A, Parks V, Lee FC. Movva S, et al. Among authors: mangalik a. Melanoma Res. 2011 Feb;21(1):76-9. doi: 10.1097/CMR.0b013e32833d3293. Melanoma Res. 2011. PMID: 21169871 Clinical Trial.

2

Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Cristofanilli M, et al. Among authors: mangalik a. Clin Cancer Res. 2010 Mar 15;16(6):1904-14. doi: 10.1158/1078-0432.CCR-09-2282. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215537 Clinical Trial.

3

Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.

Neidhart JA, Kohler W, Stidley C, Mangalik A, Plauche A, Anderson T, Quenzer RW, Rinehart JJ. Neidhart JA, et al. Among authors: mangalik a. J Clin Oncol. 1990 Oct;8(10):1728-38. doi: 10.1200/JCO.1990.8.10.1728. J Clin Oncol. 1990. PMID: 2213108

4

Pilot trial of infusional 5-fluorouracil, interleukin-2, and subcutaneous interferon-alpha for advanced renal cell carcinoma.

Elias L, Binder M, Mangalik A, Clark D, Morrison B, Altobelli KK, Smith A. Elias L, et al. Among authors: mangalik a. Am J Clin Oncol. 1999 Apr;22(2):156-61. doi: 10.1097/00000421-199904000-00010. Am J Clin Oncol. 1999. PMID: 10199450 Clinical Trial.

5

Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.

Greenblatt MS, Mangalik A, Ferguson J, Elias L. Greenblatt MS, et al. Among authors: mangalik a. Clin Cancer Res. 1995 Jun;1(6):615-20. Clin Cancer Res. 1995. PMID: 9816023 Clinical Trial.

6

Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.

Neidhart J, Mangalik A, Kohler W, Stidley C, Saiki J, Duncan P, Souza L, Downing M. Neidhart J, et al. Among authors: mangalik a. J Clin Oncol. 1989 Nov;7(11):1685-92. doi: 10.1200/JCO.1989.7.11.1685. J Clin Oncol. 1989. PMID: 2478670

7

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy.

Neidhart JA, Mangalik A, Stidley CA, Tebich SL, Sarmiento LE, Pfile JE, Oette DH, Oldham FB. Neidhart JA, et al. Among authors: mangalik a. J Clin Oncol. 1992 Sep;10(9):1460-9. doi: 10.1200/JCO.1992.10.9.1460. J Clin Oncol. 1992. PMID: 1517789 Clinical Trial.

8

Telomere content correlates with stage and prognosis in breast cancer.

Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK. Fordyce CA, et al. Among authors: mangalik a. Breast Cancer Res Treat. 2006 Sep;99(2):193-202. doi: 10.1007/s10549-006-9204-1. Epub 2006 Jun 3. Breast Cancer Res Treat. 2006. PMID: 16752076 Clinical Trial.

9

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A, et al. Leichman CG, et al. Among authors: mangalik a. J Clin Oncol. 1995 Jun;13(6):1303-11. doi: 10.1200/JCO.1995.13.6.1303. J Clin Oncol. 1995. PMID: 7751875 Clinical Trial.

10

Is "Do Everything!" Always Appropriate?

Mangalik A. Mangalik A. JAMA Oncol. 2017 Nov 1;3(11):1588. doi: 10.1001/jamaoncol.2017.1647. JAMA Oncol. 2017. PMID: 28817746 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page